Algernon Pharmaceuticals Confirms DMT Increased Growth of Neurons by 40% in Preclinical Study at Sub Hallucinogenic Dose
VANCOUVER, British Columbia, Sept. 07, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it has confirmed in its own preclinical study, that AP-188 (“N,N-Dimethyltryptamine or “DMT”), increased the growth... Read more
Filament Health Shares to Commence Trading on the OTC Market
VANCOUVER, BC, Sept. 7, 2021 /CNW/ – Filament Health Corp. (NEO: FH) (OTC Pink: FLHLF) (“Filament” or the “Company”), an exclusively-natural psychedelic drug discovery company, today announced that it received notification from the Financial Regulatory Authority (“FINRA”) that its shares are qualified to commence trading on the OTC Pink Market (the... Read more
TerrAscend to Acquire Gage Cannabis
Ryan Allway September 1st, 2021 News, Top News Establishes Leading Presence in Michigan, the Third Largest U.S. Cannabis Market Combines Industry Leading Retail, Cultivation and Operations Teams Across 7 Cultivation Facilities and 23 Operational Retail Locations in 5 States The Gage Brand, One of the Most Influential and Innovative in Michigan,... Read more
Ketamine One to Deploy Cognetivity’s Integrated Cognitive Assessment Tool
VANCOUVER, British Columbia, Sept. 01, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased to announce that it has reached a commercial... Read more
BioHarvest Sciences Inc. Successfully Delivers A Major Milestone In The Scale-up Process Of Its Cannabis Development Program
Ryan Allway September 1st, 2021 – The Company is now growing Cannabis cells with trichomes in medium-scale bioreactors representing a 250x increase in scale – On track for commercialization of Cannabis and Hemp based products in H1-2022 VANCOUVER, BC and REHOVOT, Israel, Sept. 1, 2021 /CNW/ — BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) is... Read more
The Name Change is part of a re-branding initiative in order to better align the Company’s name and image as a comprehensive leader in cannabis extraction, distillation and product manufacturing. Following a change in management, the Company decided to proceed with the Name Change for several reasons: (i) “Phyto”... Read more
Bioharvest Sciences Inc. Announces Closing of the First Tranche of Its Private Placement
Ryan Allway August 30th, 2021 News, Top News First tranche closed represents over three-quarters of the anticipated financing. Vancouver, British Columbia and Rehovot, Israel–(Newsfile Corp. – August 30, 2021) – BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) is pleased to announce that it has closed the first tranche (the “First... Read more
Ketamine One Subsidiary IRP Health Expands With New Veteran-Focused Clinics
Ryan Allway August 30th, 2021 Psychedelics, Top News Integrated Rehab and Performance Re-Branded as IRP Health to Better Reflect its Planned Evolution into a Multidisciplinary Business VANCOUVER, British Columbia, Aug. 30, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a... Read more
Psychedelic Experience: Treating the Trip that Never Ends
Robin Lefferts August 30th, 2021 Exclusive, News, Psychedelics, Top News Psychedelics, including ketamine, psilocybin, and LSD, are gaining traction in the mental health industry as they have been found to be potentially beneficial for conditions ranging from depression to anxiety to PTSD to alcoholism. As psychedelics are entering the... Read more
Decibel Cannabis Company Inc. Announces $10 Million Bought Deal Unit Offering
Ryan Allway August 26th, 2021 News, Top News CALGARY, Alberta, Aug. 26, 2021 (GLOBE NEWSWIRE) — Decibel Cannabis Company Inc. (“ Decibel ” or the “ Company ”) (TSXV: DB ) (OTCQB: DBCCF), a premium cannabis producer, is pleased to announce that it has entered into an agreement pursuant to which Eight Capital, Haywood Securities... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )